The Food and Drug Administration is facing a federal investigation into whether it correctly followed its policies and procedures in the contamination and recall of baby formula that lead to a national shortage and the potential deaths of infants.
The Department of Health and Human Services announced on Thursday that it would specifically review whether or not the FDA correctly conducted inspections of Abbott's Sturgis, Mich., manufacturing facility at the center of the recall and if it correctly oversaw Abbott's initiation of the infant formula recall.
